Replies to post #5830 on Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[BigGreen101]

ericteg,

The last 9 months of reported earning (fully normalized diluted) are as follows: Q1= 0 (reported a negative, thus they are using antidiluting method), Q2 = 0.14 and Q3 = 0.44.

Thus EPS are 0.58 for the first 9 months of this year. They might have a huge Q4 number like they did last year. We will know this in last Sept.

Overall, we are seeing an increase in revenue, but the lawsuit judgment in Q1 eliminated all profits from that quarter.

The EPS should get better once all of the capital investments have been repaid.

cheers